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n increase in extracellular Ca
 
2
 
 
 
 induces growth arrest
and differentiation of human keratinocytes in culture.
We examined possible involvement of S100C/A11
in this growth regulation. On exposure of the cells to high
Ca
 
2
 
 
 
, S100C/A11 was speciﬁcally phosphorylated at 
 
10
 
Thr
and 
 
94
 
Ser. Phosphorylation facilitated the binding of
S100C/A11 to nucleolin, resulting in nuclear translocation
of S100C/A11. In nuclei, S100C/A11 liberated Sp1/3 from
nucleolin. The resulting free Sp1/3 transcriptionally activated
p21
 
CIP1/WAF1
 
, a representative negative regulator of cell
A
 
growth. Introduction of anti-S100C/A11 antibody into the
 
cells largely abolished the growth inhibition induced by Ca
 
2
 
 
 
and the induction of p21
 
CIP1/WAF1
 
. In the human epidermis,
S100C/A11 was detected in nuclei of differentiating cells in
the suprabasal layers, but not in nuclei of proliferating cells
in the basal layer. These results indicate that S100C/A11 is
a key mediator of the Ca
 
2
 
 
 
-induced growth inhibition of
human keratinocytes in culture, and that it may be possibly
involved in the growth regulation in vivo as well.
 
Introduction
 
Exquisite spatial and temporal control of cell growth and
differentiation is a prerequisite for embryonic development
and maintenance of fine tissue architecture. The epidermis is
a typical tissue in which compartments of growing cells and
growth-arrested terminally differentiating cells are clearly
demarcated. In normal epidermis, proliferating cells are
only observed in the basal layer. On moving to the upper
layers, the cells stop growing, progressively follow a terminal
differentiation pathway, and finally shed off from the surface.
The critical step determining whether the cells withdraw
from the growing cell population is regulated by a complex
network involving many genes, but the precise molecular
mechanisms remain largely unknown.
A number of factors have been reported to trigger dif-
ferentiation of human and mouse epidermal keratinocytes
in culture, i.e., increased extracellular Ca
 
2
 
 
 
 concentration
(Hennings et al., 1980), TGF
 
 
 
 (Shipley et al., 1986), forced
expression of PKC (Ohba et al., 1998), and detachment of
cells from the substrate (Zhu and Watt, 1996). Normal
human keratinocytes (NHKs) continuously proliferate only
in a culture medium with Ca
 
2
 
 
 
 of 
 
 
 
0.1 mM. An increase in
the Ca
 
2
 
 
 
 concentration to 1.2–2.0 mM results in termination
of cell growth and induction of terminal differentiation
phenotypes (Hennings et al., 1980). An increase in the extra-
cellular Ca
 
2
 
 
 
 level resulted in a sustained higher intracellular
Ca
 
2
 
 
 
 concentration (Sharpe et al., 1989). Some other
conditions inducing differentiation of keratinocytes also
lead to increased intracellular Ca
 
2
 
 
 
 levels (Sharpe et al.,
1989; Missero et al., 1996). An increasing gradient of Ca
 
2
 
 
 
concentration is present from the basal to the cornified
layers of the epidermis in vivo (Menon et al., 1992). Mice
lacking the expression of full-length extracellular Ca
 
2
 
 
 
-sensing
receptors showed deteriorated epidermal differentiation (Ko-
muves et al., 2002). These results indicate that higher Ca
 
2
 
 
 
levels lead to induction of epidermal differentiation not only
in culture, but also in vivo.
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An elevation in the Ca
 
2
 
 
 
 level triggers a number of intra-
cellular signal transductional events, including production of
inositol 1,4,5-triphosphate and 1,2-diacylglycerol; activation
of calcineurin, PKCs, and Raf/MEK/ERK pathway; and ty-
rosine phosphorylation of p62 and fyn (Dotto, 1999;
Schmidt et al., 2000). On the other hand, it has been shown
that p21
 
CIP1/WAF1
 
 was induced 4 or 8 h after an increase in
the extracellular Ca
 
2
 
 
 
 level, leading to inhibition of Cdk ac-
tivity and blockage of cell cycle progression (Missero et al.,
1996). p21
 
CIP1/WAF1
 
 protein has been detected in cells of the
suprabasal layers, but not in those cells of the basal layer of
the human epidermis (Ponten et al., 1995). An important
missing link is how the Ca
 
2
 
 
 
-induced initial events lead to
the induction of p21
 
CIP1/WAF1
 
.
In a previous work on density-dependent growth inhibition
of normal human fibroblasts, we identified S100C/A11 (cal-
gizzarin), a member of the Ca
 
2
 
 
 
-binding S100 protein family,
as a key mediator of growth arrest (Sakaguchi et al., 2000). In
a confluent state, S100C/A11 was phosphorylated at 
 
10
 
Thr
and translocated into nuclei, and it eventually inhibited DNA
synthesis through the induction of p21
 
CIP1/WAF1
 
 and p16
 
INK4a
 
.
S100C/A11 is comprised in the epidermal differentiation
complex (EDC) located on chromosome 1q21 in humans.
EDC encodes nearly 30 genes. About half of them are specifi-
cally expressed during Ca
 
2
 
 
 
-dependent terminal differentia-
tion of keratinocytes (e.g., profilaggrin and loricrin), and the
other half are members of the S100 protein family. The S100
family proteins have been assumed to play signal transduction
roles in the differentiation of epidermis and other tissues.
Some of the S100 protein family members were differentially
expressed in normal human skin and melanocytic lesions
(Boni et al., 1997). S100C/A11 was reported to be up- or
down-regulated in malignant tumors (Van Ginkel et al.,
1998). These results prompted us to examine possible involve-
ment of S100C/A11 in growth regulation of epidermal kerati-
nocytes. Here, we show that S100C/A11 is a key mediator of
the high Ca
 
2
 
 
 
-induced growth arrest in human keratinocytes.
 
Results
 
Increase in extracellular Ca
 
2
 
 
 
 concentration inhibits 
the growth of NHK and HaCaT cells
 
At first, we confirmed that an increase in extracellular Ca
 
2
 
 
 
concentration from 0.03 to 1.5 mM results in inhibition of
DNA synthesis of NHK cells in dose- and time-dependent
manners (Fig. 1, A and B). HaCaT cells, an immortalized
human keratinocyte line (Boukamp et al., 1988), were rou-
tinely cultivated in a medium with 1.5 mM Ca
 
2
 
 
 
. When the
concentration of Ca
 
2
 
 
 
 was increased to 5 or 10 mM, DNA
synthesis of HaCaT cells was inhibited (Fig. 1, A and B).
Under similar conditions, Sharpe et al. (1989) and Gonczi
et al. (2002) reported that there was no remarkable differ-
ence in intracellular Ca
 
2
 
 
 
 level (70–100 nM) of NHK and
HaCaT cells, despite different extracellular Ca
 
2
 
 
 
 concen-
trations. Intracellular Ca
 
2
 
 
 
 concentrations in NHK and
HaCaT cells increased by 
 
 
 
40% within 30 min after in-
creasing the extracellular Ca
 
2
 
 
 
 concentrations from 0.03 to
1.5 mM and from 1.5 to 10 mM, respectively (Fig. 1 C).
Overall, the response of HaCaT cells to 10 mM Ca
 
2
 
 
 
 was
similar to that of NHK cells to 1.5 mM Ca
 
2
 
 
 
. No immedi-
 
ate cytotoxicity was noted in HaCaT cells in a medium with
10 mM Ca
 
2
 
 
 
 during the observation period. Therefore,
throughout the present work, 0.03 and 1.5 mM Ca
 
2
 
 
 
 was
used as low Ca
 
2
 
 
 
 media and 1.5 and 10 mM Ca
 
2
 
 
 
 was used
as high Ca
 
2
 
 
 
 media for NHK and HaCaT cells, respectively.
 
S100C/A11 inhibits the growth of human keratinocytes
 
To examine the possible involvement of S100C/A11 in
growth regulation of human keratinocytes, we transfected var-
ious constructs of S100C/A11 flanking SV40-derived NLS to
exponentially growing HaCaT cells. As shown in Fig. 2 A, in-
corporation of BrdU was specifically inhibited in the cells
transfected with wild-type S100C/A11 (indicated by arrows),
whereas GFP alone did not show any effects. DNA synthesis
was inhibited by 
 
 
 
25% by the wild-type S100C/A11 (Fig. 2
B). This reduction is substantial, considering that the transfec-
tion efficiency was at most 40%. Introduction of recombinant
S100C/A11 protein into HaCaT cells by the aid of the protein
transduction domain of TAT protein (YGRKKRRQRRR;
Schwarze et al., 1999) efficiently inhibited DNA synthesis
(Fig. 2 C). The TAT-flanked protein was transferred to cell
nuclei with an efficiency of nearly 100%.
 
Increase in extracellular Ca
 
2
 
 
 
 concentration results in 
phosphorylation and nuclear translocation of S100C/A11
 
When extracts of NHK and HaCaT cells labeled with
[
 
32
 
P]phosphate were analyzed by a two-dimensional gel elec-
trophoresis, increased phosphorylation of S100C/A11 (as
identified by sequencing) was noted in both cell types ex-
Figure 1. Growth arrest and increased intracellular Ca
2  levels 
of NHK and HaCaT cells exposed to high Ca
2  media. (A) Dose-
dependent inhibition of [
3H]TdR incorporation into an insoluble 
fraction in NHK (left) and HaCaT (right) cells exposed to high Ca
2  
for 6 h. (B) Time-dependent inhibition of 1  Ci/ml [
3H]TdR 
incorporation by NHK (circles) and HaCaT (squares) cells exposed 
to high Ca
2 . (C) Increases in intracellular Ca
2  levels of NHK 
(circles) and HaCaT (squares) cells. Relative intracellular Ca
2  level 
(left; the concentrations in cells cultured in low Ca
2  media are 1.0) 
and representative images (right). 
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posed to high Ca
 
2
 
 
 
 (Fig. 3 A). Exposure to high Ca
 
2
 
 
 
 in-
creased the immunoprecipitable amount of S100C/A11 and
more remarkably the level of phosphorylation in both cell
types (Fig. 3 A, bottom), whereas the S100C/A11 protein lev-
els only slightly increased by high Ca
 
2
 
 
 
 (Fig. S3, available at
http://www.jcb.org/cgi/content/full/jcb.200304017/DC1).
To determine the phosphorylation sites of S100C/A11,
endogenous S100C/A11 protein was purified from 
 
32
 
P-
labeled HaCaT cells and degradated to peptides. As shown in
Fig. 3 B (middle and bottom), only NH
 
2
 
-terminal p1-1 and
COOH-terminal p4 were phosphorylated in a totally high
Ca
 
2
 
 
 
-depending manner. When the synthesized peptides of
S100C/A11 were incubated with cell extracts in vitro, NH
 
2
 
-
terminal pepA (amino acid residues 1–23) and COOH-ter-
minal pepF (87–105), but not four other peptides covering
the middle part of S100C/A11, were significantly phosphor-
ylated by the extracts prepared from NHK and HaCaT cells
cultivated in the high Ca
 
2
 
 
 
 media (unpublished data). Thr
and Ser residues were phosphorylated in pepA and pepF, re-
spectively (Fig. 3 C). Finally, phosphorylation sites in p1-1
and p4 were determined as 
 
10
 
Thr and 
 
94
 
Ser, respectively, by
an amino acid sequencer (Fig. 3 D). In accordance with this,
Ala-substituted forms at 
 
10
 
Thr of pepA and at 
 
94
 
Ser of pepF
were not phosphorylated by the cell extracts prepared after
cultivating in the high Ca
 
2
 
 
 
 media (unpublished data).
Increases in Ca
 
2
 
 
 
 in the media resulted in partial translo-
cation of endogenous S100C/A11 to nuclei of NHK and
HaCaT cells as demonstrated by immunostaining (Fig. 4 A)
and by Western blotting and autoradiography (Fig. 4 B).
Figure 2. Growth inhibition of human epidermal keratinocytes by 
S100C/A11. (A) Various constructs of S100C/A11-NLS-Myc (top row) 
were transfected to HaCaT cells 48 h before the addition of 1  M 
BrdU. The cells were further incubated for 12 h before fixation and 
staining for Myc (top row) and BrdU (bottom row). Arrows indicate 
Myc-positive and BrdU-negative cells.  N, NH2-terminal 23 aa–
deleted form; TA, Ala-substituted form of 
10Thr; TD, Asp-substituted 
form of 
10Thr (a 
10phosphothreonine-equivalent form). Bar, 20  m. 
(B) Inhibition of 1  Ci/ml [
3H]TdR incorporation (12 h) by various 
S100C/A11-NLS-Myc constructs in HaCaT cells under conditions 
similar to A. SA, Ala-substituted form of 
94Ser; SD, Asp-substituted 
form of 
94Ser;  C, COOH-terminal 19 aa-deleted form. For the other 
abbreviations, see A. (C) Inhibition of [
3H]TdR incorporation by 
TAT-S100C/A11 protein variants in HaCaT cells. Recombinant His6-
TAT–fused S100C/A11 proteins were purified using a nickel-NTA 
chelating column and gel electrophoresis. The cells were incubated 
with each protein (10  M) for 6 h. 1  Ci/ml [
3H]TdR was added 1 h 
before harvest. For abbreviations, see B.
Figure 3. Phosphorylation of S100C/A11 in NHK and HaCaT cells 
exposed to high Ca
2  concentrations. (A) Top: two-dimensional 
electrophoresis of [
32P]phosphate-labeled cell extracts. Only a part 
covering pI (isoelectric point) 6.0–7.0, molecular marker of 
9.0–16.5 kD, is shown. The arrows show phosphorylated S100C/A11 
as identified by sequencing. Bottom: after increasing the Ca
2  
concentrations, cell extracts were immunoprecipitated with 
anti-S100C/A11 antibody and analyzed by Western blotting or 
autoradiography. (B) Top: expected partial peptides of S100C/A11 
cleaved by cyanogen bromide (for p0 and p2-4) or by cyanogen 
bromide followed by an asparatic endopeptidase (for p1-1 and p1-2). 
Asterisks indicate potential phosphorylation sites as determined 
in D. Bottom: autoradiography of the purified peptides prepared 
from [
32P]phosphate-labeled HaCaT cells exposed to high Ca
2 . 
(C) Phosphorylated amino acid residues of synthetic pepA (aa residues 
1–23), pepF (87–105), and endogenous S100C/A11. pepA and pepF 
were phosphorylated in vitro by a cell extract prepared from HaCaT 
cells exposed to high Ca
2 . (D) Determination of phosphorylation 
sites of S100C/A11. The purified p1-1 and p4 (A) were analyzed 
by an automated amino acid sequencer. Missing peaks (arrows) 
indicate the phosphorylation sites. Numerals indicate the amino 
acid residues of S100C/A11.828 The Journal of Cell Biology | Volume 163, Number 4, 2003
Preincubation with a membrane-permeable Ca
2  chelator,
BAPTA-AM, inhibited the nuclear translocation of endoge-
nous S100C/A11 by high Ca
2  (Fig. 4 A). An S100C/A11
variant protein lacking Ca
2 -binding capacity was not trans-
located to nuclei by high Ca
2  (Fig. 4 C). Transfection of
the wild-type S100C/A11-GFP construct before the shift to
high Ca
2  resulted in nuclear translocation of the protein in
HaCaT cells (Fig. 4 D). This nuclear translocation was not
observed when 
10Thr was substituted with Ala (Fig. 4 D) or
when the NH2-terminal 23 amino acids were deleted (un-
published data). 
10Thr-to-Asp–substituted protein (TD) was
observed in nuclei even in the low Ca
2  medium. On the
contrary, 
94Ser-substituted forms behaved in a manner simi-
lar to the wild-type protein. A COOH-terminal truncated
form of S100C/A11 lacking the residues from 87 to 105 was
transferred to nuclei by the high Ca
2  (unpublished data).
These results indicate that the phosphorylation of 
10Thr, but
not of 
94Ser, is critical for the Ca
2 -induced nuclear localiza-
tion of S100C/A11, and that binding of Ca
2  to S100C/
A11 is necessary for the translocation.
Binding of S100C/A11 to nucleolin is essential 
for nuclear translocation
Because S100C/A11 lacks the canonical NLS sequence, we
screened for possible interacting protein(s) using a pepA(TD)-
immobilized column (pepA with Asp at the 10th residue, a
phosphorylated pepA equivalent). An  100-kD protein was
identified in extracts of HaCaT cells as showing specific bind-
ing (Fig. 5 A, left). Sequencing of the eluted protein gave an
amino acid sequence of VKLAKAGKANQGD, correspond-
ing to the NH2 terminus of human nucleolin. The binding of
S100C/A11 and nucleolin was confirmed in vitro (Fig. 5 A,
right; Fig. 5 B). The bound amounts of nucleolin depended
on the amounts of S100C/A11 protein immobilized, and
S100C/A11(TD), a 
10Thr phosphorylation equivalent form,
showed higher affinity to nucleolin than did the wild type
(Fig. 5 B). Synthesized pepA having phosphothreonine at the
10th residue showed a higher nucleolin-binding capacity sim-
ilar to pepA(TD) (Fig. S6, available at http://www.jcb.org/
cgi/content/full/jcb.200304017/DC1). Only pepA, and not
the other five partial peptides of S100C/A11, binds to nucleo-
lin. Furthermore, neither GST-S100A2 nor GST-S100A6,
the other members of S100 family, bound to nucleolin as as-
sayed in vitro (unpublished data).
In the Ca
2 -stimulated HaCaT cells, S100C/A11 protein
that was phosphorylated and bound to nucleolin was pre-
dominantly found in the nuclei (Fig. 5 C). Among vari-
ous  GFP-conjugated 
10Thr- or 
94Ser-substituted forms of
S100C/A11 transfected to HaCaT cells, only 
10Thr-to-Asp–
substituted forms were coprecipitated with nucleolin in the
low Ca
2  medium (Fig. 5 D). In the high Ca
2  medium,
phosphorylation of S100C/A11 was observed when either
10Thr or 
94Ser was intact. Nucleolin was coprecipitated with
10Thr-intact forms in addition to 
10Thr-to-Asp–substituted
forms. BAPTA-AM inhibited the phosphorylation and in-
teraction of wild-type S100C/A11 with nucleolin by high
Figure 4. Nuclear translocation of S100C/
A11 in NHK and HaCaT cells by high Ca
2 . 
(A) Translocation of S100C/A11 to nuclei 
by high Ca
2 . NHK and HaCaT cells were 
immunostained with anti-S100C/A11 antibody. 
A membrane-permeable Ca
2  chelator, 
BAPTA-AM, was added at 30  M from 1 h 
before the increase of Ca
2  concentrations. 
(B) Cells labeled with [
32P]phosphate were 
fractionated into soluble (Sol) and insoluble 
(Insol) cytoplasmic fractions and a nuclear 
fraction (Nuc). Immunoblotting of cyclin D1 was 
used to show successful fractionation. (C) Loss 
of Ca
2 -binding capacity of S100C/A11 inhibits 
the nuclear translocation induced by high Ca
2  
in HaCaT cells. Top: successful elimination 
of Ca
2 -binding capacity of S100C/A11 as 
demonstrated by native PAGE of the recombinant 
proteins premixed with 
45Ca. Bottom: necessity 
of Ca
2  binding to S100C/A11 for the nuclear 
translocation. Plasmid constructs of wild-type (wt) 
S100C/A11 and a variant of the protein lacking 
Ca
2 -binding ( Ca) were transfected 36 h before 
the increase of Ca
2  concentration. BAPTA-AM, 
30  M. The cells were observed in living 
conditions before and 6 h after increasing the 
extracellular Ca
2  level. (D) Nuclear translocation 
of S100C/A11 is affected by the 10th residue. 
Various GFP-S100C constructs were transfected 
to HaCaT cells under conditions similar to C. 
TA, 
10Thr to A; TD, 
10Thr to D; SA, 
94Ser to A; 
SD, 
94Ser to D. Bars, 20  m (A, C, and D).S100C mediates Ca-induced growth inhibition | Sakaguchi et al. 829
Ca
2  (Fig. 5 E). The S100C/A11 variant protein lacking
Ca
2 -binding capacity was neither phosphorylated nor co-
precipitated with nucleolin by high Ca
2  (Fig. 5 E).
When small interfering RNA (siRNA) against nucleolin
was applied to HaCaT cells, the protein levels were substan-
tially reduced (Fig. 5 F, top), whereas the control siRNA
against GAPDH showed no effects. Increase in Ca
2  con-
centration translocated endogenous S100C/A11 into nuclei
in the siRNA against GAPDH-treated cells, but not in the
siRNA against nucleolin-treated cells (Fig. 5 F, bottom).
The necessity of nucleolin for the Ca
2 -induced nuclear
translocation of S100C/A11 was also confirmed in an in
vitro translocation assay using permeabilized HaCaT cells by
depleting nucleolin with a specific antibody (Fig. S5, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200304017/
DC1). These results indicate that (1) high Ca
2  treatment of
HaCaT cells induces endogenous activity to phosphorylate
S100C/A11 at 
10Thr and 
94Ser, and eventually enhances the
binding of S100C/A11 to nucleolin; (2) S100C/A11 binds
to nucleolin through its NH2-terminal region in a 
10Thr
phosphorylation–dependent manner; (3) the binding of
S100C/A11 to nucleolin is essential for the translocation
of S100C/A11 to nuclei; and (4) the binding of Ca
2  to
S100C/A11 is necessary for the phosphorylation, binding to
nucleolin, and nuclear translocation of S100C/A11.
The effector protein for growth inhibition by S100C/A11 
is p21
CIP1/WAF1
The next question is how nuclear S100C/A11 exerts its in-
hibitory action on the growth of keratinocytes. We screened
a number of possible candidates and found that p21
CIP1/WAF1
mRNA was remarkably induced in NHK cells either culti-
vated at 1.5 mM Ca
2  or exposed to TAT-S100C/A11 (Fig.
6 A). p16
INK4a was also induced, but to a moderate extent.
Similar induction was observed in HaCaT cells in a time-
dependent manner (Fig. 6 B).
To confirm the role of S100C/A11 on the induction of
p21
CIP1/WAF1, anti-S100C/A11 antibody was introduced into
HaCaT cells by the aid of Chariot or polyethyleneimine
(PEI). The polyclonal antibody that we used was specific as
shown in Fig. 6 C, and was demonstrated to recognize the
NH2-terminal pepA and COOH-terminal pepF of S100C/
A11 (unpublished data). Binding of the introduced antibody
to endogenous S100C/A11 was demonstrated by immuno-
precipitation (Fig. 6 D). Introduction of the antibody inhib-
ited the high Ca
2 -induced phosphorylation of S100C/A11
(Fig. 6 E). Fab fragments of the anti-S100C/A11 antibody
also reduced the phosphorylation of S100C/A11 in HaCaT
cells (Fig. S8, available at http://www.jcb.org/cgi/content/full/
jcb.200304017/DC1). The induction of p21
CIP1/WAF1 by
TAT-S100C/A11 was dose-dependently abrogated by the an-
tibody introduced into the cells (Fig. 6 F). The decrease in the
amount of p21
CIP1/WAF1 protein due to the action of anti-
S100C/A11 antibody was associated with the recovery of
cdk2 activity as assayed in vitro (Fig. 6 F). Inhibition of cdk2
activity by S100C/A11 introduced into HaCaT cells was
dose- and time-dependent. Finally, anti-p21
CIP1/WAF1 antibody
(but not anti-p16
INK4a antibody) completely abrogated the
growth inhibition by S100C/A11 as assayed for [
3H]TdR in-
corporation or for cdk2 activity (Fig. 6, G and H), indicating
Figure 5. Binding of phosphorylated S100C/A11 to nucleolin 
as a prerequisite for its nuclear translocation. (A) Binding of 
S100C/A11 to nucleolin. Left: HaCaT cell extract was applied 
onto a pepA(TD) column (a phosphorylated pepA equivalent), 
and the bound fraction was electrophoresed and silver stained. 
MM, molecular marker. An  100-kD protein band was 
identified (arrow). Right: S100C/A11 in the cell extract 
bound to recombinant nucleolin immobilized on a membrane. 
(B) Binding of nucleolin to S100C/A11-GST or S100C/A11(TD)-
GST beads. Extracts from HaCaT cells were applied onto the 
beads, and the bound fractions were analyzed by Western 
blotting using anti-nucleolin antibody. (C) At various times 
after increasing the Ca
2  level, cytoplasmic (C) and nuclear 
(N) extracts were prepared and analyzed by immunoblotting 
(IB) with or without prior immunoprecipitation (IP) using 
indicated antibodies. On exposure to high Ca
2 , S100C/A11 
was phosphorylated, bound to nucleolin, and transferred to 
nuclei. (D) Binding of S100C/A11 to nucleolin is affected 
by the 10th residue. Various GFP-S100C constructs were 
transfected to HaCaT cells 36 h before the increase of Ca
2  
concentration. TA, 
10Thr to A; TD, 
10Thr to D; SA, 
94Ser to A; 
SD, 
94Ser to D. TA   SA and TD   SD were double mutants. 
Immunoprecipitates of 
32P-labeled cell extracts by anti-GFP 
antibody were immunoblotted with either anti-GFP (top) or 
anti-nucleolin antibody (bottom) or autoradiographed (middle). 
(E) Necessity of Ca
2  binding to S100C for the interaction 
with nucleolin in HaCaT cells. Plasmid constructs of 
wild-type (wt) S100C/A11 and a variant lacking Ca
2 -binding 
capacity ( Ca) were transfected and analyzed under conditions 
similar to D. 30  M BAPTA-AM was added 1 h before 
increasing Ca
2  concentration. (F) Top: time-dependent reduction of the nucleolin levels in HaCaT cells by 0.2  M siRNA. Bottom: 48 h after 
the application of siRNA, extracellular Ca
2  concentration was shifted up and incubated for a further 6 h. The cells were then fixed and 
immunostained. Bar, 20  m.830 The Journal of Cell Biology | Volume 163, Number 4, 2003
that p21
CIP1/WAF1 is the principal effector protein of the
S100C/A11-mediated growth inhibition of human kerati-
nocytes. Specificity of anti-p21
CIP1/WAF1 and anti-p16
INK4a an-
tibodies was confirmed as shown in Fig. 6 C.
In nuclei, S100C/A11 competitively binds to 
nucleolin and liberates Sp1 and Sp3, which 
eventually induce p21
CIP1/WAF1
Next, we addressed the question of how S100C/A11 in the
nuclei induces the effector p21
CIP1/WAF1. Screening using Sig-
nal Transduction AntibodyArray™ (Hypromatrix) resulted
in identification of Sp1 as a protein that binds to nucleolin,
and the binding was inhibited by the addition of S100C/
A11(TD) (Fig. 7 A). Anti-Sp2 antibody (but not anti-Sp3
antibody) was also on the membrane, but showed a negative
result. Binding of Sp1 to nucleolin was confirmed by apply-
ing the extract of HaCaT cells onto GST-nucleolin beads
(Fig. 7 B). Sp1 did not bind directly to S100C/A11.
To examine whether nucleolin binds to Sp1 in the cells,
we performed a coprecipitation assay (Fig. 7 C). Sp1 and
S100C/A11 were detected in the precipitates prepared using
anti-nucleolin antibody, whereas nucleolin, but not S100C/
A11, was detected in the precipitates prepared using anti-
Sp1 antibody. These results indicate that binding among the
proteins actually takes place in vivo, and that S100C/A11
does not bind to Sp1. In HaCaT cells cultivated in the pres-
ence of 1.5 mM Ca
2 , nucleolin bound to Sp1, but not to
S100C/A11. When the Ca
2  concentration was increased to
10 mM, S100C/A11 instead of Sp1 was detected in the im-
munoprecipitates prepared using anti-nucleolin antibody,
and the bound S100C/A11 was phosphorylated. When the
extract was treated with alkaline phosphatase in advance, the
amount of S100C/A11 bound to nucleolin was dramatically
reduced and the binding of Sp1 was recovered concomi-
tantly. Immunoprecipitation with anti-Sp1 antibody con-
firmed that the stimulation with high Ca
2  liberated Sp1
from nucleolin.
Regions of nucleolin and Sp1 involved in the interaction
were determined using recombinant partial proteins (Fig. 7
E). The COOH-terminal region of Sp1 (segment 3) includ-
Figure 6. Induction of Cdk inhibitors and 
concomitant inhibition of Cdk2 by S100C/A11. 
(A) Induction of p21
CIP1/WAF1 and p16
INK4a by 
TAT-S100C/A11 or high Ca
2  applied to NHK 
cells for 6 h as assayed by Northern blot analysis. 
(B) Time-dependent induction of p21
CIP1/WAF1 and 
p16
INK4a by TAT-S100C/A11 or high Ca
2  in HaCaT 
cells. (C) Specificity of antibodies used. HaCaT cells 
with (Tr.) or without (Cont.) transfection of each 
construct were analyzed by Western blotting. MM, 
molecular marker. (D) Binding of anti-S100C/A11 
antibody to S100C/A11 in HaCaT cells. Anti-S100C/
A11 antibody and the control IgG were introduced 
into the cells by Chariot (Chart) or polyethyleneimine 
(PEI). 2 h later, fractions of cell extracts bound to 
protein G were immunoblotted using anti-S100C/
A11 antibody. L, light chain of the antibodies; 
PEI-L, light chain of the antibodies conjugated 
with PEI. (E) Blocking of the phosphorylation of 
S100C/A11 by anti-S100C/A11 antibody introduced 
into cells. The antibody and IgG were introduced 
as in D. Anti-S100C/A11 antibody was added to 
the cell extracts to pull down S100C/A11 in the 
IgG-treated group as well. The antibodies were 
recovered by protein A and the bound proteins were 
analyzed by Western blotting using anti-S100C/A11 
antibody (top) or by autoradiography (bottom). 
(F) Induction of p21
CIP1/WAF1 protein by TAT-S100C/
A11 was blocked by anti-S100C/A11 antibody 
introduced into HaCaT cells. TAT-S100C/A11 was 
applied 6 h before the application of the antibody. 
At various times after applying the antibodies, cell 
extracts were immunoblotted using anti-S100C/A11 
antibody (closed circle, L-chain; open arrowhead, 
His6-TAT-S100C; closed arrowhead, endogenous 
S100C/A11), anti-p21
CIP1/WAF1, or anti-tubulin. The 
extracts were immunoprecipitated with anti-cyclin E 
antibody and blotted with anti-Cdk2 antibody. 
Amounts and radioactivity of histone H1, the 
substrate of in vitro Cdk2 kinase assay, were shown. 
(G) Anti-p21
CIP1/WAF1 antibody blocked growth 
inhibition by S100C/A11. HaCaT cells were 
incubated with the indicated antibodies with Chariot. 2 h later, TAT-S100C/A11 was applied and the cells were cultivated for 6 h before 
harvest. (H) Under experimental conditions similar to G, anti-p21
CIP1/WAF1 antibody (but not anti-p16
INK4a antibody) blocked the inhibition of 
Cdk2 activity by TAT-S100C/A11.S100C mediates Ca-induced growth inhibition | Sakaguchi et al. 831
ing a zinc-finger domain was shown to be responsible for the
binding to nucleolin (Fig. 7 D, top). In turn, Sp1 in the cell
extract bound to segment 4 of nucleolin immobilized on a
membrane (Fig. 7 D, middle). Recombinant Sp1 segment 3
also bound to the nucleolin segment 4, indicating direct in-
teraction between the two proteins. S100C/A11 was recov-
ered only from beads conjugated with segment 3 of nucleo-
lin (Fig. 7 D, bottom). When segment 3 of nucleolin was
introduced into HaCaT cells, the Ca
2 -induced p21
CIP1/WAF1
protein level was decreased and the activity of cdk2 was re-
covered within 8 h, despite continuous cultivation at 10
mM Ca
2  (unpublished data). This is possibly due to a
dominant-negative effect of the peptide through sequester-
ing S100C/A11 by binding. The interacting regions of the
proteins are depicted in Fig. 7 E.
Binding of nucleolin in cell extracts to Sp1 (segment 3)
was dose-dependently inhibited by recombinant S100C/
A11 (Fig. 7 F). S100C/A11(TD) showed a stronger effect,
whereas S100C/A11(TA) did not affect the binding between
nucleolin and Sp1 (segment 3).
Because Sp3 is also known to activate the p21
CIP1/WAF1
promoter (Prowse et al., 1997), we examined possible inter-
action with nucleolin and S100C/A11 and found that (1)
Sp3 can bind to nucleolin segment 4 via its COOH-termi-
nal zinc-finger domain; and (2) the binding of Sp3 to nucle-
olin was inhibited by S100C/A11 (unpublished data).
A gel shift assay was performed using GC-rich regions of
the p21
CIP1/WAF1 promoter, the well-known Sp1/Sp3-binding
sites (see Materials and methods). As shown in Fig. 7 G, ex-
posure of NHK and HaCaT cells to high Ca
2  resulted in an
increase in the intensity of the shifted bands by Sp1 and Sp3,
which were further retarded by the addition of anti-Sp1 or
-Sp3 antibody. Under similar experimental conditions in
which HaCaT cells were cultivated in a high Ca
2  medium,
addition of GST-nucleolin into the incubation mixtures in-
hibited the extent of the band shift as compared with GST
(Fig. 7 G, right). This was possibly due to sequestration of
Sp1 by exogenous nucleolin. The inhibition of the band shift
by GST-nucleolin was abrogated by the 
10Thr phosphoryla-
tion equivalent form S100C/A11(TD), whereas wild-type
S100C/A11 and S100A2 showed no effect. We found that
the interaction of the proteins were dose-dependent, and ad-
dition of an excess amount of wild-type S100C/A11 showed
recovering effects similar to S100C/A11(TD) (unpublished
data). These results indicate the competitive nature of the
binding between S100C/A11 and Sp1/Sp3 to nucleolin. We
performed a series of luciferase assays using a plasmid con-
taining the p21
CIP1/WAF1 promoter region (Nakano et al.,
1997) and obtained essentially the same results as those ob-
tained by using the gel shift assay (unpublished data). Dele-
tion of the Sp1/Sp3-binding sites in the promoter abrogated
the induction of luciferase activity by S100C/A11.
Biological relevance of the S100C/A11 pathway as a 
mediator of the growth inhibition of keratinocytes
The findings described in the previous paragraphs indicate
that S100C/A11 is involved in growth inhibition of human
keratinocytes induced by high Ca
2  (Fig. 8 A). Under low
Ca
2  conditions, S100C/A11 is present mostly in the cyto-
plasm. The unphosphorylated S100C/A11 partly binds to
Figure 7. Induction of p21
CIP1/WAF1 via Sp1 by S100C/A11. 
(A) HaCaT cell extract was applied onto Signal Transduction 
AntibodyArray™, followed by incubation with either GST-nucleolin 
alone or GST-nucleolin mixed with S100C/A11(TD), and was 
visualized with HRP-conjugated anti-GST antibody. The arrows 
indicate spots showing positive binding to nucleolin and specific 
abrogation of the binding by the presence of S100C/A11(TD). The 
spot is anti-Sp1 antibody. Incubation with either GST-S100C/A11 or 
GST was used as a background control. (B) HaCaT cell extract was 
incubated with beads conjugated with GST, GST-S100C/A11, or 
GST-nucleolin. Sp1 in the extract bound to nucleolin, but not to 
S100C/A11. (C) HaCaT cell extracts were immunoprecipitated with 
anti-nucleolin or anti-Sp1 antibody, followed by blotting with 
indicated antibodies. A part of the extracts was treated with alkaline 
phosphatase before immunoprecipitation. (D) Binding regions of 
Sp1 and nucleolin were determined using recombinant partial 
proteins indicated in E. Sp1: Seg-1, residues 1–260; Seg-2, residues 
261–540; Seg-3, residues 541–785. Nucleolin: Seg-1, residues 1–141; 
Seg-2, residues 142–270; Seg-3, residues 271–643; Seg-4, residues 
644–707. Top: nucleolin in the HaCaT cell extract bound to Seg-3 
of Sp1. Middle: Sp1 in the cell extract and recombinant Sp1 Seg-3 
bound to Seg-4 of nucleolin. Bottom: S100C/A11 was recovered 
only from beads conjugated with Seg-3 of nucleolin. (E) Schematic 
representation of interacting segments of Sp1, nucleolin, and 
S100C/A11. (F) Interaction among Sp1, nucleolin, and S100C/A11. 
HaCaT cell extracts were applied onto an immobilized recombinant 
Sp1 Seg-3 column and the bound fractions were analyzed by 
Western blotting using anti-nucleolin antibody. (G) A gel shift assay 
performed using the GC-rich regions of the human p21
CIP1/WAF1 
promoter as probes. Left: nuclear extracts were mixed with the 
probes with or without an antibody against Sp1 or Sp3. Expected 
positions of shifted bands (open arrowhead for Sp1 and open circle 
for Sp3) and super-shifted bands by the antibodies (closed arrowhead 
for Sp1 and closed circle for Sp3) are indicated. Right: under similar 
conditions, the band shift was abrogated by addition of GST-nucleolin. 
The amount of the shifted bands reduced by nucleolin was recovered 
when S100C/A11(TD) (but not wild-type S100C/A11 or S100A2) was 
added into the reaction tube. Amounts of recombinant proteins, 1  g.832 The Journal of Cell Biology | Volume 163, Number 4, 2003
actin fiber via its COOH-terminal region (unpublished
data). An increase in intracellular Ca
2  results in activa-
tion of an as-yet-unidentified protein kinase(s) that phos-
phorylates S100C/A11 at 
10Thr and 
94Ser. Phosphorylated
S100C/A11 binds to nucleolin via its NH2-terminal region
and is translocated to nuclei. In the nuclei, S100C/A11
competes with Sp1 and Sp3 for binding to nucleolin, and
the resulting free Sp1 and Sp3 induce p21
CIP1/WAF1.
A question that arises is to what extent the pathway is bio-
logically relevant. To address this question, anti-S100C/A11
antibody was introduced into NHK and HaCaT cells by PEI
and Chariot, respectively. The introduction efficiency was
confirmed to be  70% by immunostaining. The introduced
antibody inhibited the high Ca
2 -induced phosphorylation
of S100C/A11 (Fig. 6 E). High Ca
2  suppressed DNA syn-
thesis to  17% of the control level, and the antibody recov-
ered the DNA synthesis to 64 and 72% of the control level in
NHK and HaCaT cells, respectively, indicating that S100C/
A11 is a principal (if not sole) mediator of growth regulation
(Fig. 8 B). The incomplete recovery may be either due to in-
complete blockage of S100C/A11 function by the intro-
duced antibody or due to the presence of some additional
pathway mediating high Ca
2 -induced growth inhibition.
S100C/A11 was found to be expressed at various levels in
many human tissues (Fig. 8 C), among which skin showed a
particularly high level of S100C/A11 expression. When nor-
mal human skin tissues were stained with anti-S100C/A11
antibody, S100C/A11 protein was detected in epidermal ke-
ratinocytes (Fig. 8 D). Nuclei of cells in the basal layer were
consistently negative for S100C/A11 protein, whereas nuclei
of cells in the suprabasal layers were positive. p21
CIP1/WAF1
protein was not detected in the basal layer, but appeared in
suprabasal cell nuclei in which S100C/A11 was present.
Among 21 nuclei counted in the basal layer, 20 and 1 nu-
clei were negative and positive for both S100C/A11 and
p21
CIP1/WAF1, respectively. In the suprabasal layer, 89 nu-
clei were positive for S100C/A11 and p21
CIP1/WAF1, whereas
11 nuclei were positive for S100C/A11, but negative for
p21
CIP1/WAF1. No S100C/A11-negative nuclei expressed
p21
CIP1/WAF1. These results indicate that S100C/A11 not
only mediates high Ca
2 -induced growth inhibition of hu-
man keratinocytes in culture, but most likely plays a key role
in the growth regulation in vivo as well.
Discussion
We have demonstrated that an S100C/A11-mediated path-
way plays a key role in high Ca
2 -induced growth inhibition
of human keratinocytes in culture. This finding has substan-
tial biological significance for the following reasons: (1) high
Ca
2  is a physiological inducer of growth arrest and differen-
tiation of human keratinocytes in culture, and probably in
vivo as well; (2) prior introduction of anti-S100C/A11 anti-
body resulted in recovery of the high Ca
2 -induced growth
inhibition of human keratinocytes by  70%, indicating that
S100C/A11 is a key (if not the sole) mediator of growth reg-
ulation; and (3) immunostaining of the human epidermis for
S100C/A11 and p21
CIP1/WAF1 showed a picture consistent
with the model presented as a summary of the results of the
present report using cultured human keratinocytes (Fig. 8 A).
Phosphorylation and nuclear translocation of S100C/A11
Endogenous S100C/A11 was phosphorylated at 
10Thr and
94Ser in HaCaT cells exposed to high Ca
2  (Fig. 3 D),
Figure 8. An S100C/A11-mediated pathway for 
inhibition of cell growth and implication of its 
biological significance. (A) A schematic diagram of the 
S100C/A11-mediated pathway revealed in the present 
paper. (B) Significance of the S100C/A11-mediated 
pathway in Ca
2 -induced growth inhibition of human 
keratinocytes. Anti-S100C/A11 antibody was introduced 
2 h before increasing the Ca
2  concentrations, and the 
cells were cultivated for a further 10 h. (C) Northern 
blot analysis of various human tissues for S100C/A11 
expression. PBL, peripheral blood leukocytes. 
(D) Immunostaining of normal human epidermis for 
S100C/A11 and p21
CIP1/WAF1 protein in paraffin (left) 
and frozen (right) sections. The nuclei of cells in the 
basal layer were specifically free from S100C/A11 
protein (left). In the double-staining picture, note 
that p21
CIP1/WAF1 was detected only in the nuclei that 
were positive for S100C/A11 (right). Dotted line 
indicates the boundary between the epidermis and 
dermis. Bars, 20  m.S100C mediates Ca-induced growth inhibition | Sakaguchi et al. 833
whereas only 
10Thr was shown to be the major target of
phosphorylation in confluent normal human fibroblasts
(Sakaguchi et al., 2000). The phosphorylation of S100C/
A11 at 
10Thr stimulated binding to nucleolin via its NH2-
terminal region, this being a prerequisite for nuclear translo-
cation of S100C/A11 (Fig. 5, C–F). In human kerati-
nocytes, some of the cytoplasmic S100C/A11 proteins were
colocalized with actin fibers. We found that S100C/A11
binds to actin through the COOH-terminal region and that
phosphorylation of 
94Ser reduced the affinity (unpublished
data). The liberation of S100C/A11 from actin may facili-
tate the association with nucleolin and the eventual nuclear
translocation of S100C/A11.
Ca
2  binds to S100C/A11 and induces its conforma-
tional changes (Rety et al., 2000). The binding of Ca
2  to
S100C/A11 appears to be critical for the S100C/A11-
mediated growth inhibition because interference of the
binding either by amino acid substitution or with a mem-
brane-permeable Ca
2  chelator (BAPTA-AM) inhibited
phosphorylation, binding to nucleolin, and nuclear trans-
location of S100C/A11 (Fig. 4, A and C; Fig. 5 E). Cellu-
lar kinase activity for S100C/A11 as assayed in vitro using
S100C/A11 or pepA was induced by high Ca
2  in NHK
and HaCaT cells. The kinase activity was detected in a cy-
tosolic-soluble fraction, but not in an insoluble or nuclear
fraction, of HaCaT cells exposed to high Ca
2 . When the
cell extract was applied onto a cation exchange column, the
activity was eluted with 160–180 mM KCl (unpublished
data). Further characterization of the kinase(s) is now in
progress in our laboratory.
Interaction among nucleolin, S100C/A11, and Sp1/Sp3
Nucleolin was first identified as a protein involved in riboso-
mal assembly and maturation, but was later found to have
diverse biological functions (Srivastava and Pollard, 1999).
Although nucleolin is mainly localized in the nucleus, it
shuttles between the nucleus and cytoplasm and is even
present on the cell surface. When we microinjected wheat
germ hemagglutinin into HaCaT cells, which is known to
generally inhibit nuclear import of proteins (Finlay and
Forbes, 1990), nucleolin was diffusely distributed in the cells
(unpublished data). Recently, Shibata et al. (2002) reported
that nucleolin mediates a signal from the cell surface to the
nucleus. Nucleolin inhibited transcriptional activation by
A-Myb through specific binding (Ying et al., 2000). Heat
shock or irradiation was shown to mobilize nucleolin from
nucleoli to promote the formation of a nucleolin–p53 com-
plex (Daniely et al., 2002). In the present work, we showed
that S100C/A11 and Sp1/Sp3 compete for binding to nu-
cleolin. This is the first report of nucleolin providing a site
for switching transcriptional activation through protein–
protein interaction. Unexpectedly, it was found that S100C/
A11 and Sp1/Sp3 bind to different regions of nucleolin (Fig.
7 E). Binding of S100C/A11 may change the conformation
of nucleolin so that it can no longer hold Sp1 and Sp3. Al-
though nucleolin is notoriously sticky, the interaction with
Sp1/3 and S100C/A11 is unlikely to be nonspecific because
(1) only the specific regions of the respective proteins show
the binding capacity; and (2) other members of S100, such
as S100A2 and S100A6, did not bind to nucleolin.
Transcriptional activation of p21
CIP1/WAF1 by Sp1 and Sp3
Sp1/krupple-like factors act as ubiquitous and tissue-
restricted transactivators in many different contexts. Sp1
and Sp3 were shown to activate the p21
CIP1/WAF1 promoter
(Prowse et al., 1997). In the gel shift assay, the shifted bands
shown in Fig. 7 G were further retarded by incubation with
anti-Sp1 and anti-Sp3 antibody. We performed a series of
luciferase assays using the plasmid containing the human
p21
CIP1/WAF1 promoter sequence of 2.4 kb (Nakano et al.,
1997). Application of TAT-S100C/A11 induced the activ-
ity of the p21
CIP1/WAF1 promoter by more than 10-fold in
HaCaT cells in an Sp1/Sp3 site-dependent manner (unpub-
lished data). This induction was abrogated by pretreatment
of the cells with TAT-nucleolin segment 3, but not TAT-
nucleolin segment 4. These results indicate that p21
CIP1/WAF1,
the effector protein of S100C/A11-mediated growth inhibi-
tion (Fig. 6 G), is transcriptionally activated by Sp1 and Sp3
in human keratinocytes when exposed to high Ca
2 . This
induction must be p53-independent because HaCaT cells
are known to have only mutated p53 genes (Lehman et al.,
1993).
Biological effects of p21
CIP1/WAF1 in human keratinocytes
There remains little doubt that p21
CIP1/WAF1, when expressed,
inhibits the growth of keratinocytes through inactivating
Cdks (Gartel et al., 1996). The results of immunostaining
for p21
CIP1/WAF1 (Fig. 8 D) suggest that p21
CIP1/WAF1 is in-
volved in growth arrest and differentiation of human epider-
mal keratinocytes in vivo. Various differentiation factors for
human keratinocytes, including high Ca
2  (Todd and Rey-
nolds, 1998), TGF  (Datto et al., 1995), and TPA (Todd
and Reynolds, 1998), are known to induce p21
CIP1/WAF1.
In the human epidermis, p21
CIP1/WAF1 protein was de-
tected in the lower and middle suprabasal layers, but not in
the uppermost layers (Fig. 8 D; Ponten et al., 1995). This
seems reasonable because overexpressed p21
CIP1/WAF1 was
shown to inhibit terminal differentiation of mouse kerati-
nocytes at later stages (Di Cunto et al., 1998). Alternatively,
p21
CIP1/WAF1 may simply not be needed in irreversibly ar-
rested cells.
Regulation of growth and differentiation in keratinocytes
TGF  transduces signals via Smad proteins. In HaCaT
cells treated with TGF , Smad3 and Smad4 were found to
cooperate with Sp1 for transcriptional activation of the
p21
CIP1/WAF1 promoter (Pardali et al., 2000). When we
treated HaCaT and NHK cells with TGF , S100C/A11
was translocated to nuclei (unpublished data). Thus,
S100C/A11 may be a partial converging point of high
Ca
2  and TGF .
The proposed S100C/A11-mediated pathway for Ca
2 -
induced growth arrest (Fig. 8 A) has partly revealed the
thus-far-unknown link from the initial events triggered by
high Ca
2  to the induction of Cdk inhibitors, particularly
p21
CIP1/WAF1. However, we still have little information on
how S100C/A11 is phosphorylated upon stimulation by
high Ca
2 . The specific phosphorylation observed in the
present paper in terms of culture conditions and substrates
(Fig. 3, B and D) provides an opportunity for the identifica-
tion of the involved protein kinase(s). Furthermore, the834 The Journal of Cell Biology | Volume 163, Number 4, 2003
function of S100C/A11 for liberation of Sp1 and Sp3 in nu-
clei was born by residues 1–23 of the NH2-terminal peptide.
Considering the ubiquitous expressions of nucleolin and
Sp1/Sp3 and the large variety of promoters that are regulated
by Sp1 and Sp3, further narrowing down of the functional
structural domain of the peptide and screening for chemicals
that have similar structure may be a promising venture even-
tually leading to pharmacologically useful substances.
Materials and methods
Cells
NHK cells (Kurabo Industries, Ltd.) were cultured in Defined Keratinocyte-
SFM (GIBCO BRL) with Defined Keratinocyte-SFM Growth Supplement
(GIBCO BRL). HaCaT cells, a gift from Dr. Fusenig (German Cancer Re-
search Center, Heidelberg, Germany), were cultured in DME with 10%
FBS. For monitoring DNA synthesis, 1  Ci/ml tritiated thymidine ([
3H]TdR;
American Radiolabeled Chemicals) was added to the cultures 1 h before
cell harvest. An anti-BrdU antibody (Neomarkers) was used to stain BrdU-
incorporated cells. Subfractionation of cells was performed as described
previously (Lindeman et al., 1997). Imaging analysis of the intracellular
Ca
2  level was performed as reported previously (Yamamoto et al., 2000).
Determination of phosphorylation sites
To determine the phosphorylation sites of endogenous S100C/A11, the pro-
tein was collected from HaCaT cells cultivated in the low or high Ca
2  me-
dium using an affinity column with anti-S100C/A11 antibody. After further
purification by PAGE, the protein was cleaved with cyanogen bromide and
the peptides were fractionated by HPLC. Four peptides (Fig. 3 D) were iden-
tified by partial sequencing. pep1 was further cleaved with endoproteinase
Asp-N (Roche). The purified p1-1 and p4 were subjected to NH2-terminal
sequencing on a peptide sequencer (model 491; Applied Biosystems).
Phosphorylated amino acid residues were run through the column, and
thus disappeared from the expected position of unphosphorylated residues.
Introduction of proteins into cells
Peptides and S100C/A11 protein with relatively low molecular sizes were
introduced into cells by the aid of the protein transduction domain of TAT
protein (YGRKKRRQRRR) from human immunodeficiency virus (Schwarze
et al., 1999). A Chariot kit (active motif) and cationic PEI-conjugated
S100C/A11 antibody were used to introduce antibodies into HaCaT and
NHK cells, respectively. To functionally inactivate proteins within the
cells, rabbit anti–human S100C/A11, mouse anti–human p16
INK4a (Ab-4,
clone 16P04; Neomarkers), and mouse anti-p21
CIP1/WAF1 (Ab-11, clone
CP74: Neomarkers) antibodies were used. The anti-S100C/A11 antibody
detects only a single band in Western blot analysis using cells irrespective
to Ca
2  levels in the media (Fig. 6 C). Efficacy for neutralization of the tar-
get proteins p16
INK4a and p21
CIP1/WAF1 by the antibodies was confirmed by
in vitro phosphorylation assay.
Antibodies and plasmid constructs
Antibodies and plasmid constructs used in the present work are listed in
the Online supplemental material section.
siRNA
An optimal target site of nucleolin mRNA for siRNA was determined as 5 -
GACAGTGATGAAGAGGAGG-3  by a program provided by QIAGEN,
and the synthetic siRNA was purchased from the same company. siRNA
against GAPDH mRNA (Ambion) was used as a control. The siRNA was
transfected to the logarithmically growing HaCaT cells using Lipo-
fectAMINE™ 2000 (Invitrogen).
Cdk2 kinase assay
An in vitro cdk2 kinase assay was performed using immunoprecipitates
with anti–human cyclin E antibody and histone H1 as a substrate as de-
scribed previously (Ohashi et al., 1999).
Antibody array
Signal Transduction AntibodyArray™ (Hypromatrix) was used under the
conditions indicated by the manufacturer. In brief, the antibody membrane
was incubated with 1-mg HaCaT cell extracts, followed by the application
of 10- g full-length recombinant proteins (GST, GST-S100C/A11, GST-
nucleolin, or GST-nucleolin   S100C/A11(TD)). After washing, the bound
proteins were detected using HRP-conjugated anti-GST antibody (Santa
Cruz Biotechnology, Inc.).
Gel shift assay
A gel mobility shift assay was performed as described by Nakano et al.
(1997). We used GC-rich regions located between 120 and 94 bp (A), 93
and 74 bp (B), and 73 and 47 bp (C) of the human p21
CIP1/WAF1 promoter as
probes. The 
32P-labeled probes (A   B   C; 10
4 cpm) were mixed with 4
 g crude nuclear extracts of NHK or HaCaT cells, incubated for 20 min at
RT, and electrophoresed in a 5% polyacrylamide gel under nondenaturing
conditions. For a super-shift experiment, 1  g mouse anti–human Sp1 anti-
body (Santa Cruz Biotechnology, Inc.) or rabbit anti–human Sp3 antibody
(Santa Cruz Biotechnology, Inc.) was added to the reaction mixture.
Acquisition and processing of images
For GFP-labeled vital cells, images were acquired by a fluorescent micro-
scope (IX71–22FL/PH; CCD camera, DP50; objective lens, LCPlan F1
40 ; Olympus) and processed using Adobe Photoshop
® 6.0. For fixed
cells labeled with FITC, Alexa
® 488, or TRITC, a laser-scanning micro-
scope (Axioplan 2; objective lens, Plan-Apochromat
® 63  1.4 oil DC and
Plan-Neofluar
® 40 /0.75; Carl Zeiss MicroImaging, Inc.) was used.
Online supplemental material
Fig. S1 shows dose-dependent inhibition of DNA synthesis by TAT-S100C.
Fig. S2 shows expression of variant S100C/A11 proteins. Fig. S3 shows ef-
fects of high Ca
2  on endogenous S100C/A11 levels. Fig. S4 depicts intra-
cellular localization of nucleolin. Fig. S5 shows necessity of nucleolin for
nuclear translocation of S100C/A11. Fig. S6 depicts binding of S100C/A11
pepA with nucleolin. Fig. S7 shows proteins recovered by protein G from
HaCaT cells applied with anti-S100C antibody or IgG. Fig. S8 shows Fab
of anti-S100C/A11 antibody and reduced phosphorylation level of S100C/
A11 induced by high Ca
2 . Fig. S9 depicts induction of p21
CIP1/WAF1 by
variant S100C/A11 proteins. Fig. S10 shows interaction among nucleolin,
Sp1, and S100C/A11. Fig. S11 shows competition of S100C/A11 peptides
with Sp1 and Sp3 for binding to nucleolin. Fig. S12 shows the dominant-
negative effect of nucleolin Seg-3 for the induction of p21
CIP1/WAF1 by TAT-
S100C/A11. The supplemental material is available at http://www.jcb.org/
cgi/content/full/jcb.200304017/DC1.
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